# A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

> **NCT00547469** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Dynogen Pharmaceuticals** · enrollment: 360 (estimated)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DRUG:** DDP733

## Key facts

- **NCT ID:** NCT00547469
- **Lead sponsor:** Dynogen Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2008-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00547469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00547469, "A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00547469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*